> top > docs > PMC:3218875 > spans > 24005-25236 > annotations

PMC:3218875 / 24005-25236 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T12563 563-569 Regulation denotes effect
T12562 477-487 Gene_expression denotes expression
T12561 203-207 Regulation denotes role
T12560 138-142 Transcription denotes mRNA
T12559 116-120 Positive_regulation denotes high
T12558 75-82 Positive_regulation denotes induced
T12543 674-680 Protein denotes ABIN-1
T12542 532-535 Protein denotes A20
T12541 521-527 Protein denotes ABIN-3
T12540 234-237 Protein denotes A20
T12539 212-218 Protein denotes ABIN-1
T12538 131-137 Protein denotes ABIN-1
T12537 71-74 Protein denotes TNF
T12536 43-49 Protein denotes ABIN-1
R8312 T12537 T12558 causeOf TNF,induced
R8313 T12541 T12562 themeOf ABIN-3,expression
R8314 T12542 T12562 themeOf A20,expression

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T13554 910-914 VBP denotes show
T13604 1230-1231 . denotes .
T13603 1228-1230 NNP denotes RA
T13602 1223-1227 IN denotes with
T13601 1212-1222 VBN denotes associated
T13600 1207-1211 RB denotes also
T13599 1203-1206 VBP denotes are
T13598 1189-1202 NNS denotes erythematosus
T13597 1183-1188 NN denotes lupus
T13596 1174-1182 JJ denotes systemic
T13595 1169-1173 IN denotes with
T13594 1158-1168 VBN denotes associated
T13593 1155-1157 VB denotes be
T13592 1152-1154 TO denotes to
T13591 1143-1151 VBN denotes reported
T13590 1138-1142 VBN denotes been
T13589 1133-1137 VBP denotes have
T13588 1128-1132 WDT denotes that
T13587 1123-1127 NNS denotes SNPs
T13586 1115-1122 IN denotes whether
T13585 1103-1114 VB denotes investigate
T13584 1100-1102 TO denotes to
T13583 1088-1099 JJ denotes interesting
T13582 1085-1087 VB denotes be
T13581 1075-1084 RB denotes therefore
T13580 1070-1074 MD denotes will
T13579 1067-1069 PRP denotes It
T13578 1065-1066 . denotes .
T13577 1064-1065 -RRB- denotes )
T13576 1055-1064 NN denotes rituximab
T13575 1054-1055 -LRB- denotes (
T13574 1044-1053 NN denotes depletion
T13573 1037-1043 NNP denotes B-cell
T13572 1034-1036 IN denotes as
T13571 1029-1033 JJ denotes such
T13570 1018-1028 NNS denotes treatments
T13569 1015-1017 TO denotes to
T13568 1006-1014 NN denotes response
T13567 1002-1005 CC denotes and
T13566 993-1001 NNS denotes features
T13565 984-992 JJ denotes systemic
T13564 982-983 , denotes ,
T13563 972-982 NN denotes production
T13562 959-971 JJ denotes autoantibody
T13561 957-958 , denotes ,
T13560 946-957 NN denotes involvement
T13559 940-945 JJ denotes joint
T13558 937-939 IN denotes in
T13557 929-936 VBP denotes overlap
T13556 920-928 JJ denotes clinical
T13555 915-919 DT denotes some
T13553 901-909 NNS denotes diseases
T13552 897-900 CD denotes two
T13551 893-896 DT denotes the
T13550 890-892 IN denotes as
T13549 881-889 VBN denotes expected
T13548 878-880 VB denotes be
T13547 872-877 MD denotes might
T13546 867-871 NN denotes loci
T13545 852-866 NN denotes susceptibility
T13544 849-851 NNP denotes RA
T13543 845-848 CC denotes and
T13542 831-844 NNS denotes erythematosus
T13541 825-830 NN denotes lupus
T13540 816-824 JJ denotes systemic
T13539 808-815 IN denotes between
T13538 800-807 VBP denotes overlap
T13537 797-799 IN denotes of
T13536 790-796 NN denotes degree
T13535 785-789 JJ denotes high
T13534 783-784 DT denotes A
T13533 781-782 . denotes .
T13532 780-781 NNP denotes ]
T13531 775-780 CD denotes 61,62
T13530 774-775 NNP denotes [
T13529 767-773 NNS denotes humans
T13528 764-766 IN denotes in
T13527 750-763 VBZ denotes erythematosus
T13526 744-749 NN denotes lupus
T13525 735-743 JJ denotes systemic
T13524 731-734 CC denotes and
T13523 721-730 NN denotes psoriasis
T13522 716-720 IN denotes with
T13521 705-715 VBN denotes associated
T13520 700-704 VBN denotes been
T13519 695-699 VBP denotes have
T13518 681-694 NNS denotes polymorphisms
T13517 674-680 JJ denotes ABIN-1
T13516 672-673 , denotes ,
T13515 659-672 RB denotes Interestingly
T13514 657-658 . denotes .
T13513 656-657 NNP denotes ]
T13512 654-656 CD denotes 60
T13511 653-654 NNP denotes [
T13510 641-652 NNS denotes macrophages
T13509 632-640 JJ denotes synovial
T13508 622-631 NNS denotes arthritis
T13507 609-621 JJ denotes inflammatory
T13506 606-608 IN denotes in
T13505 595-605 VBN denotes suppressed
T13504 586-594 RB denotes strongly
T13503 582-585 VBD denotes was
T13502 577-581 NNP denotes ITAM
T13501 573-576 DT denotes the
T13500 570-572 IN denotes of
T13499 563-569 NN denotes effect
T13498 552-562 JJ denotes protective
T13497 547-551 DT denotes this
T13496 545-546 , denotes ,
T13495 537-545 RB denotes Moreover
T13494 535-536 . denotes .
T13493 532-535 NNP denotes A20
T13492 528-531 CC denotes and
T13491 521-527 JJ denotes ABIN-3
T13490 512-520 NNS denotes proteins
T13489 501-511 NN denotes inhibitory
T13488 495-500 JJ denotes NF-κB
T13487 491-494 DT denotes the
T13486 488-490 IN denotes of
T13485 477-487 NN denotes expression
T13484 473-476 DT denotes the
T13483 470-472 IN denotes on
T13482 463-469 VB denotes depend
T13481 460-462 TO denotes to
T13480 454-459 VBN denotes shown
T13479 450-453 VBD denotes was
T13478 440-449 NNS denotes receptors
T13477 432-439 VBN denotes coupled
T13476 431-432 : denotes -
T13475 430-431 -RRB- denotes )
T13474 426-430 NNP denotes ITAM
T13473 425-426 -LRB- denotes (
T13472 419-424 NN denotes motif
T13471 408-418 NN denotes activation
T13470 393-407 JJ denotes tyrosine-based
T13469 378-392 JJ denotes immunoreceptor
T13468 375-377 IN denotes by
T13467 365-374 NNS denotes responses
T13466 361-364 NNP denotes TLR
T13465 358-360 IN denotes of
T13464 347-357 NN denotes inhibition
T13463 345-346 , denotes ,
T13462 340-345 NN denotes study
T13461 333-339 JJ denotes recent
T13460 331-332 DT denotes a
T13459 328-330 IN denotes In
T13458 326-327 . denotes .
T13457 325-326 NNP denotes ]
T13456 323-325 CD denotes 59
T13455 322-323 NNP denotes [
T13454 319-321 NNP denotes RA
T13453 316-318 IN denotes of
T13452 303-315 NN denotes pathogenesis
T13451 299-302 DT denotes the
T13450 295-298 CC denotes and
T13449 284-294 NN denotes signalling
T13448 278-283 JJ denotes NF-κB
T13447 275-277 IN denotes of
T13446 264-274 NN denotes regulation
T13445 255-263 NN denotes feedback
T13444 246-254 JJ denotes negative
T13443 242-245 DT denotes the
T13442 239-241 IN denotes in
T13441 237-238 , denotes ,
T13440 234-237 NNP denotes A20
T13439 229-233 IN denotes with
T13438 220-228 RB denotes together
T13437 218-219 , denotes ,
T13436 212-218 NNP denotes ABIN-1
T13435 208-211 IN denotes for
T13434 203-207 NN denotes role
T13433 193-202 JJ denotes potential
T13432 191-192 DT denotes a
T13431 180-190 VBG denotes indicating
T13430 178-179 , denotes ,
T13429 170-178 NNS denotes biopsies
T13428 163-169 NN denotes tissue
T13427 160-162 NNP denotes RA
T13426 157-159 IN denotes in
T13425 148-156 VBN denotes detected
T13424 143-147 VBD denotes were
T13423 138-142 NNP denotes mRNA
T13422 131-137 NNP denotes ABIN-1
T13421 128-130 IN denotes of
T13420 121-127 NNS denotes levels
T13419 116-120 JJ denotes high
T13418 112-115 CC denotes and
T13417 110-111 , denotes ,
T13416 98-110 NNS denotes synoviocytes
T13415 92-97 JJ denotes human
T13414 89-91 IN denotes in
T13413 83-88 NNS denotes genes
T13412 71-82 JJ denotes TNF-induced
T13411 65-70 IN denotes among
T13410 54-64 VBN denotes identified
T13409 50-53 VBD denotes was
T13408 43-49 NN denotes ABIN-1
T13407 41-42 , denotes ,
T13406 33-41 NN denotes analysis
T13405 22-32 NN denotes microarray
T13404 6-21 NN denotes oligonucleotide
T13403 0-5 VBG denotes Using
R8954 T13403 T13410 advcl Using,identified
R8955 T13404 T13406 nmod oligonucleotide,analysis
R8956 T13405 T13406 compound microarray,analysis
R8957 T13406 T13403 dobj analysis,Using
R8958 T13407 T13410 punct ",",identified
R8959 T13408 T13410 nsubjpass ABIN-1,identified
R8960 T13409 T13410 auxpass was,identified
R8961 T13410 T13410 ROOT identified,identified
R8962 T13411 T13410 prep among,identified
R8963 T13412 T13413 amod TNF-induced,genes
R8964 T13413 T13411 pobj genes,among
R8965 T13414 T13410 prep in,identified
R8966 T13415 T13416 amod human,synoviocytes
R8967 T13416 T13414 pobj synoviocytes,in
R8968 T13417 T13410 punct ",",identified
R8969 T13418 T13410 cc and,identified
R8970 T13419 T13420 amod high,levels
R8971 T13420 T13425 nsubjpass levels,detected
R8972 T13421 T13420 prep of,levels
R8973 T13422 T13423 compound ABIN-1,mRNA
R8974 T13423 T13421 pobj mRNA,of
R8975 T13424 T13425 auxpass were,detected
R8976 T13425 T13410 conj detected,identified
R8977 T13426 T13425 prep in,detected
R8978 T13427 T13429 compound RA,biopsies
R8979 T13428 T13429 compound tissue,biopsies
R8980 T13429 T13426 pobj biopsies,in
R8981 T13430 T13425 punct ",",detected
R8982 T13431 T13425 advcl indicating,detected
R8983 T13432 T13434 det a,role
R8984 T13433 T13434 amod potential,role
R8985 T13434 T13431 dobj role,indicating
R8986 T13435 T13434 prep for,role
R8987 T13436 T13435 pobj ABIN-1,for
R8988 T13437 T13431 punct ",",indicating
R8989 T13438 T13439 advmod together,with
R8990 T13439 T13425 prep with,detected
R8991 T13440 T13439 pobj A20,with
R8992 T13441 T13425 punct ",",detected
R8993 T13442 T13425 prep in,detected
R8994 T13443 T13446 det the,regulation
R8995 T13444 T13446 amod negative,regulation
R8996 T13445 T13446 compound feedback,regulation
R8997 T13446 T13442 pobj regulation,in
R8998 T13447 T13446 prep of,regulation
R8999 T13448 T13449 compound NF-κB,signalling
R9000 T13449 T13447 pobj signalling,of
R9001 T13450 T13449 cc and,signalling
R9002 T13451 T13452 det the,pathogenesis
R9003 T13452 T13449 conj pathogenesis,signalling
R9004 T13453 T13452 prep of,pathogenesis
R9005 T13454 T13455 compound RA,[
R9006 T13455 T13453 pobj [,of
R9007 T13456 T13457 nummod 59,]
R9008 T13457 T13452 appos ],pathogenesis
R9009 T13458 T13425 punct .,detected
R9010 T13459 T13480 prep In,shown
R9011 T13460 T13462 det a,study
R9012 T13461 T13462 amod recent,study
R9013 T13462 T13459 pobj study,In
R9014 T13463 T13480 punct ",",shown
R9015 T13464 T13480 nsubjpass inhibition,shown
R9016 T13465 T13464 prep of,inhibition
R9017 T13466 T13467 compound TLR,responses
R9018 T13467 T13465 pobj responses,of
R9019 T13468 T13467 prep by,responses
R9020 T13469 T13472 amod immunoreceptor,motif
R9021 T13470 T13472 amod tyrosine-based,motif
R9022 T13471 T13472 compound activation,motif
R9023 T13472 T13468 pobj motif,by
R9024 T13473 T13474 punct (,ITAM
R9025 T13474 T13472 appos ITAM,motif
R9026 T13475 T13474 punct ),ITAM
R9027 T13476 T13472 punct -,motif
R9028 T13477 T13478 amod coupled,receptors
R9029 T13478 T13480 nsubjpass receptors,shown
R9030 T13479 T13480 auxpass was,shown
R9031 T13480 T13480 ROOT shown,shown
R9032 T13481 T13482 aux to,depend
R9033 T13482 T13480 xcomp depend,shown
R9034 T13483 T13482 prep on,depend
R9035 T13484 T13485 det the,expression
R9036 T13485 T13483 pobj expression,on
R9037 T13486 T13485 prep of,expression
R9038 T13487 T13490 det the,proteins
R9039 T13488 T13490 amod NF-κB,proteins
R9040 T13489 T13490 compound inhibitory,proteins
R9042 T13491 T13485 appos ABIN-3,expression
R9043 T13492 T13491 cc and,ABIN-3
R9044 T13493 T13491 conj A20,ABIN-3
R9045 T13494 T13480 punct .,shown
R9046 T13495 T13505 advmod Moreover,suppressed
R9047 T13496 T13505 punct ",",suppressed
R9048 T13497 T13499 det this,effect
R9049 T13498 T13499 amod protective,effect
R9050 T13499 T13505 nsubjpass effect,suppressed
R9051 T13500 T13499 prep of,effect
R9052 T13501 T13502 det the,ITAM
R9053 T13502 T13500 pobj ITAM,of
R9054 T13503 T13505 auxpass was,suppressed
R9055 T13504 T13505 advmod strongly,suppressed
R9056 T13505 T13505 ROOT suppressed,suppressed
R9057 T13506 T13505 prep in,suppressed
R9058 T13507 T13508 amod inflammatory,arthritis
R9059 T13508 T13506 pobj arthritis,in
R9060 T13509 T13510 amod synovial,macrophages
R9061 T13510 T13511 compound macrophages,[
R9062 T13511 T13505 dobj [,suppressed
R9063 T13512 T13513 nummod 60,]
R9064 T13513 T13511 appos ],[
R9065 T13514 T13505 punct .,suppressed
R9066 T13515 T13521 advmod Interestingly,associated
R9067 T13516 T13521 punct ",",associated
R9068 T13517 T13518 amod ABIN-1,polymorphisms
R9069 T13518 T13521 nsubjpass polymorphisms,associated
R9070 T13519 T13521 aux have,associated
R9071 T13520 T13521 auxpass been,associated
R9072 T13521 T13521 ROOT associated,associated
R9073 T13522 T13521 prep with,associated
R9074 T13523 T13522 pobj psoriasis,with
R9075 T13524 T13523 cc and,psoriasis
R9076 T13525 T13526 amod systemic,lupus
R9077 T13526 T13523 conj lupus,psoriasis
R9078 T13527 T13521 conj erythematosus,associated
R9079 T13528 T13527 prep in,erythematosus
R9080 T13529 T13528 pobj humans,in
R9081 T13530 T13532 compound [,]
R9082 T13531 T13532 compound "61,62",]
R9083 T13532 T13521 nsubjpass ],associated
R9084 T13533 T13521 punct .,associated
R9085 T13534 T13536 det A,degree
R9086 T13535 T13536 amod high,degree
R9087 T13536 T13549 nsubjpass degree,expected
R9088 T13537 T13536 prep of,degree
R9089 T13538 T13537 pobj overlap,of
R9090 T13539 T13538 prep between,overlap
R9091 T13540 T13542 amod systemic,erythematosus
R9092 T13541 T13542 compound lupus,erythematosus
R9093 T13542 T13539 pobj erythematosus,between
R9094 T13543 T13542 cc and,erythematosus
R9095 T13544 T13545 compound RA,susceptibility
R9096 T13545 T13546 compound susceptibility,loci
R9097 T13546 T13542 conj loci,erythematosus
R9098 T13547 T13549 aux might,expected
R9099 T13548 T13549 auxpass be,expected
R9100 T13549 T13549 ROOT expected,expected
R9101 T13550 T13554 mark as,show
R9102 T13551 T13553 det the,diseases
R9103 T13552 T13553 nummod two,diseases
R9104 T13553 T13554 nsubj diseases,show
R9105 T13554 T13549 advcl show,expected
R9106 T13555 T13557 det some,overlap
R9107 T13556 T13557 amod clinical,overlap
R9108 T13557 T13554 dobj overlap,show
R9109 T13558 T13557 prep in,overlap
R9110 T13559 T13560 amod joint,involvement
R9111 T13560 T13558 pobj involvement,in
R9112 T13561 T13557 punct ",",overlap
R9113 T13562 T13563 compound autoantibody,production
R9114 T13563 T13557 conj production,overlap
R9115 T13564 T13563 punct ",",production
R9116 T13565 T13566 amod systemic,features
R9117 T13566 T13563 conj features,production
R9118 T13567 T13566 cc and,features
R9119 T13568 T13566 conj response,features
R9120 T13569 T13568 prep to,response
R9121 T13570 T13569 pobj treatments,to
R9122 T13571 T13572 amod such,as
R9123 T13572 T13570 prep as,treatments
R9124 T13573 T13574 compound B-cell,depletion
R9125 T13574 T13572 pobj depletion,as
R9126 T13575 T13574 punct (,depletion
R9127 T13576 T13574 appos rituximab,depletion
R9128 T13577 T13574 punct ),depletion
R9129 T13578 T13549 punct .,expected
R9130 T13579 T13582 nsubj It,be
R9131 T13580 T13582 aux will,be
R9132 T13581 T13582 advmod therefore,be
R9133 T13582 T13582 ROOT be,be
R9134 T13583 T13582 acomp interesting,be
R9135 T13584 T13585 aux to,investigate
R9136 T13585 T13582 xcomp investigate,be
R9137 T13586 T13601 mark whether,associated
R9138 T13587 T13601 nsubjpass SNPs,associated
R9139 T13588 T13591 nsubjpass that,reported
R9140 T13589 T13591 aux have,reported
R9141 T13590 T13591 auxpass been,reported
R9142 T13591 T13587 relcl reported,SNPs
R9143 T13592 T13594 aux to,associated
R9144 T13593 T13594 auxpass be,associated
R9145 T13594 T13591 xcomp associated,reported
R9146 T13595 T13594 prep with,associated
R9147 T13596 T13598 amod systemic,erythematosus
R9148 T13597 T13598 compound lupus,erythematosus
R9149 T13598 T13595 pobj erythematosus,with
R9150 T13599 T13601 auxpass are,associated
R9151 T13600 T13601 advmod also,associated
R9152 T13601 T13585 ccomp associated,investigate
R9153 T13602 T13601 prep with,associated
R9154 T13603 T13602 pobj RA,with
R9155 T13604 T13582 punct .,be
R9041 T13490 T13486 pobj proteins,of

DLUT931

Id Subject Object Predicate Lexical cue
T13722 463-469 Regulation denotes depend
T13721 477-487 Gene_expression denotes expression
T13705 674-680 Protein denotes ABIN-1
T13704 532-535 Protein denotes A20
T13703 521-527 Protein denotes ABIN-3
T13702 234-237 Protein denotes A20
T13701 212-218 Protein denotes ABIN-1
T13700 131-137 Protein denotes ABIN-1
T13699 71-74 Protein denotes TNF
T13698 43-49 Protein denotes ABIN-1
R9199 T13703 T13721 themeOf ABIN-3,expression
R9207 T13721 T13722 themeOf expression,depend
R9200 T13704 T13721 themeOf A20,expression
R9208 T13721 T13722 themeOf expression,depend

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T13627 71-74 http://www.uniprot.org/uniprot/P01375 denotes TNF
T13621 674-680 http://www.uniprot.org/uniprot/Q15025 denotes ABIN-1
T13620 212-218 http://www.uniprot.org/uniprot/Q15025 denotes ABIN-1
T13619 131-137 http://www.uniprot.org/uniprot/Q15025 denotes ABIN-1
T13618 43-49 http://www.uniprot.org/uniprot/Q15025 denotes ABIN-1
T13612 532-535 http://www.uniprot.org/uniprot/P21580 denotes A20
T13611 234-237 http://www.uniprot.org/uniprot/P21580 denotes A20

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T12736 674-680 Protein denotes ABIN-1
T12735 532-535 Protein denotes A20
T12734 521-527 Protein denotes ABIN-3
T12733 234-237 Protein denotes A20
T12732 212-218 Protein denotes ABIN-1
T12731 131-137 Protein denotes ABIN-1
T12730 71-74 Protein denotes TNF
T12729 43-49 Protein denotes ABIN-1

2_test

Id Subject Object Predicate Lexical cue
21639951-12965196-4289487 323-325 12965196 denotes 59
21639951-20362473-4289488 654-656 20362473 denotes 60
21639951-19169254-4289489 775-777 19169254 denotes 61
21639951-19838195-4289490 778-780 19838195 denotes 62

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T13114 1228-1230 NN denotes RA
T13113 1223-1227 IN denotes with
T13112 1212-1222 VB denotes associated
T13111 1207-1211 RB denotes also
T13110 1203-1206 VB denotes are
T13109 1189-1202 NN denotes erythematosus
T13108 1183-1188 NN denotes lupus
T13107 1174-1182 JJ denotes systemic
T13106 1169-1173 IN denotes with
T13105 1158-1168 VB denotes associated
T13104 1155-1157 VB denotes be
T13103 1152-1154 TO denotes to
T13102 1143-1151 VB denotes reported
T13101 1138-1142 VB denotes been
T13100 1133-1137 VB denotes have
T13099 1128-1132 WDT denotes that
T13098 1123-1127 NN denotes SNPs
T13097 1115-1122 IN denotes whether
T13096 1103-1114 VB denotes investigate
T13095 1100-1102 TO denotes to
T13094 1088-1099 JJ denotes interesting
T13093 1085-1087 VB denotes be
T13092 1075-1084 RB denotes therefore
T13091 1070-1074 MD denotes will
T13090 1067-1069 PRP denotes It
T13089 1064-1065 -RRB- denotes )
T13088 1055-1064 NN denotes rituximab
T13087 1054-1055 -LRB- denotes (
T13086 1044-1053 NN denotes depletion
T13085 1037-1043 NN denotes B-cell
T13084 1034-1036 IN denotes as
T13083 1029-1033 JJ denotes such
T13082 1018-1028 NN denotes treatments
T13081 1015-1017 TO denotes to
T13080 1006-1014 NN denotes response
T13079 1002-1005 CC denotes and
T13078 993-1001 NN denotes features
T13077 984-992 JJ denotes systemic
T13076 982-983 -COMMA- denotes ,
T13075 972-982 NN denotes production
T13074 959-971 NN denotes autoantibody
T13073 957-958 -COMMA- denotes ,
T13072 946-957 NN denotes involvement
T13071 940-945 JJ denotes joint
T13070 937-939 IN denotes in
T13069 929-936 NN denotes overlap
T13068 920-928 JJ denotes clinical
T13067 915-919 DT denotes some
T13066 910-914 VB denotes show
T13065 901-909 NN denotes diseases
T13064 897-900 CD denotes two
T13063 893-896 DT denotes the
T13062 890-892 IN denotes as
T13061 881-889 VB denotes expected
T13060 878-880 VB denotes be
T13059 872-877 MD denotes might
T13058 867-871 NN denotes loci
T13057 852-866 NN denotes susceptibility
T13056 849-851 NN denotes RA
T13055 845-848 CC denotes and
T13054 831-844 NN denotes erythematosus
T13053 825-830 NN denotes lupus
T13052 816-824 JJ denotes systemic
T13051 808-815 IN denotes between
T13050 800-807 NN denotes overlap
T13049 797-799 IN denotes of
T13048 790-796 NN denotes degree
T13047 785-789 JJ denotes high
T13046 783-784 DT denotes A
T13045 780-781 -RRB- denotes ]
T13044 775-780 CD denotes 61,62
T13043 774-775 -LRB- denotes [
T13042 767-773 NN denotes humans
T13041 764-766 IN denotes in
T13040 750-763 NN denotes erythematosus
T13039 744-749 NN denotes lupus
T13038 735-743 JJ denotes systemic
T13037 731-734 CC denotes and
T13036 721-730 NN denotes psoriasis
T13035 716-720 IN denotes with
T13034 705-715 VB denotes associated
T13033 700-704 VB denotes been
T13032 695-699 VB denotes have
T13031 681-694 NN denotes polymorphisms
T13030 674-680 NN denotes ABIN-1
T13029 672-673 -COMMA- denotes ,
T13028 659-672 RB denotes Interestingly
T13027 656-657 -RRB- denotes ]
T13026 654-656 CD denotes 60
T13025 653-654 -LRB- denotes [
T13024 641-652 NN denotes macrophages
T13023 632-640 JJ denotes synovial
T13022 622-631 NN denotes arthritis
T13021 609-621 JJ denotes inflammatory
T13020 606-608 IN denotes in
T13019 595-605 VB denotes suppressed
T13018 586-594 RB denotes strongly
T13017 582-585 VB denotes was
T13016 577-581 NNP denotes ITAM
T13015 573-576 DT denotes the
T13014 570-572 IN denotes of
T13013 563-569 NN denotes effect
T13012 552-562 JJ denotes protective
T13011 547-551 DT denotes this
T13010 545-546 -COMMA- denotes ,
T13009 537-545 RB denotes Moreover
T13008 532-535 NN denotes A20
T13007 528-531 CC denotes and
T13006 521-527 NN denotes ABIN-3
T13005 512-520 NN denotes proteins
T13004 501-511 JJ denotes inhibitory
T13003 495-500 NN denotes NF-κB
T13002 491-494 DT denotes the
T13001 488-490 IN denotes of
T13000 477-487 NN denotes expression
T12999 473-476 DT denotes the
T12998 470-472 IN denotes on
T12997 463-469 VB denotes depend
T12996 460-462 TO denotes to
T12995 454-459 VB denotes shown
T12994 450-453 VB denotes was
T12993 440-449 NN denotes receptors
T12992 431-439 JJ denotes -coupled
T12991 430-431 -RRB- denotes )
T12990 426-430 NN denotes ITAM
T12989 425-426 -LRB- denotes (
T12988 419-424 NN denotes motif
T12987 408-418 NN denotes activation
T12986 393-407 JJ denotes tyrosine-based
T12985 378-392 NN denotes immunoreceptor
T12984 375-377 IN denotes by
T12983 365-374 NN denotes responses
T12982 361-364 NN denotes TLR
T12981 358-360 IN denotes of
T12980 347-357 NN denotes inhibition
T12979 345-346 -COMMA- denotes ,
T12978 340-345 NN denotes study
T12977 333-339 JJ denotes recent
T12976 331-332 DT denotes a
T12975 328-330 IN denotes In
T12974 325-326 -RRB- denotes ]
T12973 323-325 CD denotes 59
T12972 322-323 -LRB- denotes [
T12971 319-321 NN denotes RA
T12970 316-318 IN denotes of
T12969 303-315 NN denotes pathogenesis
T12968 299-302 DT denotes the
T12967 295-298 CC denotes and
T12966 284-294 NN denotes signalling
T12965 278-283 NN denotes NF-κB
T12964 275-277 IN denotes of
T12963 264-274 NN denotes regulation
T12962 255-263 NN denotes feedback
T12961 246-254 JJ denotes negative
T12960 242-245 DT denotes the
T12959 239-241 IN denotes in
T12958 237-238 -COMMA- denotes ,
T12957 234-237 NN denotes A20
T12956 229-233 IN denotes with
T12955 220-228 RB denotes together
T12954 218-219 -COMMA- denotes ,
T12953 212-218 NN denotes ABIN-1
T12952 208-211 IN denotes for
T12951 203-207 NN denotes role
T12950 193-202 JJ denotes potential
T12949 191-192 DT denotes a
T12948 180-190 VB denotes indicating
T12947 178-179 -COMMA- denotes ,
T12946 170-178 NN denotes biopsies
T12945 163-169 NN denotes tissue
T12944 160-162 NN denotes RA
T12943 157-159 IN denotes in
T12942 148-156 VB denotes detected
T12941 143-147 VB denotes were
T12940 138-142 NN denotes mRNA
T12939 131-137 NN denotes ABIN-1
T12938 128-130 IN denotes of
T12937 121-127 NN denotes levels
T12936 116-120 JJ denotes high
T12935 112-115 CC denotes and
T12934 110-111 -COMMA- denotes ,
T12933 98-110 NN denotes synoviocytes
T12932 92-97 JJ denotes human
T12931 89-91 IN denotes in
T12930 83-88 NN denotes genes
T12929 71-82 JJ denotes TNF-induced
T12928 65-70 IN denotes among
T12927 54-64 VB denotes identified
T12926 50-53 VB denotes was
T12925 43-49 NN denotes ABIN-1
T12924 41-42 -COMMA- denotes ,
T12923 33-41 NN denotes analysis
T12922 22-32 NN denotes microarray
T12921 6-21 NN denotes oligonucleotide
T12920 0-5 VB denotes Using
R8555 T12923 T12920 arg2Of analysis,Using
R8556 T12923 T12921 arg1Of analysis,oligonucleotide
R8557 T12923 T12922 arg1Of analysis,microarray
R8558 T12925 T12920 arg1Of ABIN-1,Using
R8559 T12925 T12926 arg1Of ABIN-1,was
R8560 T12925 T12927 arg2Of ABIN-1,identified
R8561 T12927 T12926 arg2Of identified,was
R8562 T12927 T12928 arg1Of identified,among
R8563 T12927 T12931 arg1Of identified,in
R8564 T12927 T12935 arg1Of identified,and
R8565 T12930 T12928 arg2Of genes,among
R8566 T12930 T12929 arg1Of genes,TNF-induced
R8567 T12933 T12931 arg2Of synoviocytes,in
R8568 T12933 T12932 arg1Of synoviocytes,human
R8569 T12935 T12920 modOf and,Using
R8570 T12935 T12924 arg1Of and,","
R8571 T12935 T12934 arg1Of and,","
R8572 T12937 T12936 arg1Of levels,high
R8573 T12937 T12938 arg1Of levels,of
R8574 T12937 T12941 arg1Of levels,were
R8575 T12937 T12942 arg2Of levels,detected
R8576 T12940 T12938 arg2Of mRNA,of
R8577 T12940 T12939 arg1Of mRNA,ABIN-1
R8578 T12942 T12935 arg2Of detected,and
R8579 T12942 T12941 arg2Of detected,were
R8580 T12942 T12943 arg1Of detected,in
R8581 T12942 T12947 arg1Of detected,","
R8582 T12942 T12948 modOf detected,indicating
R8583 T12946 T12943 arg2Of biopsies,in
R8584 T12946 T12944 arg1Of biopsies,RA
R8585 T12946 T12945 arg1Of biopsies,tissue
R8586 T12951 T12948 arg2Of role,indicating
R8587 T12951 T12949 arg1Of role,a
R8588 T12951 T12950 arg1Of role,potential
R8589 T12951 T12952 arg1Of role,for
R8590 T12951 T12956 arg1Of role,with
R8591 T12951 T12958 arg1Of role,","
R8592 T12951 T12959 arg1Of role,in
R8593 T12952 T12954 arg1Of for,","
R8594 T12953 T12952 arg2Of ABIN-1,for
R8595 T12956 T12954 arg2Of with,","
R8596 T12956 T12955 arg1Of with,together
R8597 T12957 T12956 arg2Of A20,with
R8598 T12963 T12960 arg1Of regulation,the
R8599 T12963 T12961 arg1Of regulation,negative
R8600 T12963 T12962 arg1Of regulation,feedback
R8601 T12963 T12964 arg1Of regulation,of
R8602 T12963 T12967 arg1Of regulation,and
R8603 T12966 T12964 arg2Of signalling,of
R8604 T12966 T12965 arg1Of signalling,NF-κB
R8605 T12967 T12959 arg2Of and,in
R8606 T12969 T12967 arg2Of pathogenesis,and
R8607 T12969 T12968 arg1Of pathogenesis,the
R8608 T12969 T12970 arg1Of pathogenesis,of
R8609 T12971 T12970 arg2Of RA,of
R8610 T12971 T12972 arg1Of RA,[
R8611 T12973 T12972 arg2Of 59,[
R8612 T12974 T12972 arg3Of ],[
R8613 T12978 T12975 arg2Of study,In
R8614 T12978 T12976 arg1Of study,a
R8615 T12978 T12977 arg1Of study,recent
R8616 T12980 T12981 arg1Of inhibition,of
R8617 T12980 T12984 arg1Of inhibition,by
R8618 T12980 T12994 arg1Of inhibition,was
R8619 T12980 T12995 arg2Of inhibition,shown
R8620 T12980 T12997 arg1Of inhibition,depend
R8621 T12983 T12981 arg2Of responses,of
R8622 T12983 T12982 arg1Of responses,TLR
R8623 T12990 T12989 arg2Of ITAM,(
R8624 T12991 T12989 arg3Of ),(
R8625 T12993 T12984 arg2Of receptors,by
R8626 T12993 T12985 arg1Of receptors,immunoreceptor
R8627 T12993 T12986 arg1Of receptors,tyrosine-based
R8628 T12993 T12987 arg1Of receptors,activation
R8629 T12993 T12988 arg1Of receptors,motif
R8630 T12993 T12989 arg1Of receptors,(
R8631 T12993 T12992 arg1Of receptors,-coupled
R8632 T12995 T12975 arg1Of shown,In
R8633 T12995 T12979 arg1Of shown,","
R8634 T12995 T12994 arg2Of shown,was
R8635 T12997 T12995 arg3Of depend,shown
R8636 T12997 T12996 arg1Of depend,to
R8637 T12997 T12998 arg1Of depend,on
R8638 T13000 T12998 arg2Of expression,on
R8639 T13000 T12999 arg1Of expression,the
R8640 T13000 T13001 arg1Of expression,of
R8641 T13005 T13002 arg1Of proteins,the
R8642 T13005 T13003 arg1Of proteins,NF-κB
R8643 T13005 T13004 arg1Of proteins,inhibitory
R8644 T13006 T13007 arg1Of ABIN-3,and
R8645 T13007 T13001 arg2Of and,of
R8646 T13007 T13005 arg1Of and,proteins
R8647 T13008 T13007 arg2Of A20,and
R8648 T13013 T13011 arg1Of effect,this
R8649 T13013 T13012 arg1Of effect,protective
R8650 T13013 T13014 arg1Of effect,of
R8651 T13013 T13017 arg1Of effect,was
R8652 T13013 T13019 arg2Of effect,suppressed
R8653 T13016 T13014 arg2Of ITAM,of
R8654 T13016 T13015 arg1Of ITAM,the
R8655 T13019 T13009 arg1Of suppressed,Moreover
R8656 T13019 T13010 arg1Of suppressed,","
R8657 T13019 T13017 arg2Of suppressed,was
R8658 T13019 T13018 arg1Of suppressed,strongly
R8659 T13019 T13020 arg1Of suppressed,in
R8660 T13024 T13020 arg2Of macrophages,in
R8661 T13024 T13021 arg1Of macrophages,inflammatory
R8662 T13024 T13022 arg1Of macrophages,arthritis
R8663 T13024 T13023 arg1Of macrophages,synovial
R8664 T13024 T13025 arg1Of macrophages,[
R8665 T13026 T13025 arg2Of 60,[
R8666 T13027 T13025 arg3Of ],[
R8667 T13031 T13030 arg1Of polymorphisms,ABIN-1
R8668 T13031 T13032 arg1Of polymorphisms,have
R8669 T13031 T13033 arg1Of polymorphisms,been
R8670 T13031 T13034 arg2Of polymorphisms,associated
R8671 T13034 T13028 arg1Of associated,Interestingly
R8672 T13034 T13029 arg1Of associated,","
R8673 T13034 T13032 arg2Of associated,have
R8674 T13034 T13033 arg2Of associated,been
R8675 T13034 T13035 arg1Of associated,with
R8676 T13036 T13037 arg1Of psoriasis,and
R8677 T13037 T13035 arg2Of and,with
R8678 T13037 T13041 arg1Of and,in
R8679 T13040 T13037 arg2Of erythematosus,and
R8680 T13040 T13038 arg1Of erythematosus,systemic
R8681 T13040 T13039 arg1Of erythematosus,lupus
R8682 T13042 T13041 arg2Of humans,in
R8683 T13042 T13043 arg1Of humans,[
R8684 T13044 T13043 arg2Of "61,62",[
R8685 T13045 T13043 arg3Of ],[
R8686 T13048 T13046 arg1Of degree,A
R8687 T13048 T13047 arg1Of degree,high
R8688 T13048 T13049 arg1Of degree,of
R8689 T13048 T13051 arg1Of degree,between
R8690 T13048 T13059 arg1Of degree,might
R8691 T13048 T13060 arg1Of degree,be
R8692 T13048 T13061 arg2Of degree,expected
R8693 T13050 T13049 arg2Of overlap,of
R8694 T13054 T13052 arg1Of erythematosus,systemic
R8695 T13054 T13053 arg1Of erythematosus,lupus
R8696 T13054 T13055 arg1Of erythematosus,and
R8697 T13055 T13051 arg2Of and,between
R8698 T13058 T13055 arg2Of loci,and
R8699 T13058 T13056 arg1Of loci,RA
R8700 T13058 T13057 arg1Of loci,susceptibility
R8701 T13061 T13059 arg2Of expected,might
R8702 T13061 T13060 arg2Of expected,be
R8703 T13061 T13062 arg1Of expected,as
R8704 T13065 T13063 arg1Of diseases,the
R8705 T13065 T13064 arg1Of diseases,two
R8706 T13065 T13066 arg1Of diseases,show
R8707 T13066 T13062 arg2Of show,as
R8708 T13066 T13070 arg1Of show,in
R8709 T13069 T13066 arg2Of overlap,show
R8710 T13069 T13067 arg1Of overlap,some
R8711 T13069 T13068 arg1Of overlap,clinical
R8712 T13072 T13071 arg1Of involvement,joint
R8713 T13072 T13073 arg1Of involvement,","
R8714 T13073 T13076 arg1Of ",",","
R8715 T13075 T13073 arg2Of production,","
R8716 T13075 T13074 arg1Of production,autoantibody
R8717 T13076 T13079 arg1Of ",",and
R8718 T13078 T13076 arg2Of features,","
R8719 T13078 T13077 arg1Of features,systemic
R8720 T13079 T13070 arg2Of and,in
R8721 T13080 T13079 arg2Of response,and
R8722 T13080 T13081 arg1Of response,to
R8723 T13082 T13081 arg2Of treatments,to
R8724 T13082 T13084 arg1Of treatments,as
R8725 T13084 T13083 arg1Of as,such
R8726 T13086 T13084 arg2Of depletion,as
R8727 T13086 T13085 arg1Of depletion,B-cell
R8728 T13086 T13087 arg1Of depletion,(
R8729 T13088 T13087 arg2Of rituximab,(
R8730 T13089 T13087 arg3Of ),(
R8731 T13093 T13091 arg2Of be,will
R8732 T13093 T13092 arg1Of be,therefore
R8733 T13094 T13093 arg2Of interesting,be
R8734 T13096 T13090 arg1Of investigate,It
R8735 T13096 T13091 arg1Of investigate,will
R8736 T13096 T13093 arg1Of investigate,be
R8737 T13096 T13094 arg1Of investigate,interesting
R8738 T13096 T13095 arg1Of investigate,to
R8739 T13098 T13099 arg1Of SNPs,that
R8740 T13098 T13100 arg1Of SNPs,have
R8741 T13098 T13101 arg1Of SNPs,been
R8742 T13098 T13102 arg2Of SNPs,reported
R8743 T13098 T13104 arg1Of SNPs,be
R8744 T13098 T13105 arg2Of SNPs,associated
R8745 T13098 T13110 arg1Of SNPs,are
R8746 T13098 T13112 arg2Of SNPs,associated
R8747 T13102 T13100 arg2Of reported,have
R8748 T13102 T13101 arg2Of reported,been
R8749 T13105 T13102 arg3Of associated,reported
R8750 T13105 T13103 arg1Of associated,to
R8751 T13105 T13104 arg2Of associated,be
R8752 T13105 T13106 arg1Of associated,with
R8753 T13109 T13106 arg2Of erythematosus,with
R8754 T13109 T13107 arg1Of erythematosus,systemic
R8755 T13109 T13108 arg1Of erythematosus,lupus
R8756 T13112 T13096 arg2Of associated,investigate
R8757 T13112 T13097 arg1Of associated,whether
R8758 T13112 T13110 arg2Of associated,are
R8759 T13112 T13111 arg1Of associated,also
R8760 T13112 T13113 arg1Of associated,with
R8761 T13114 T13113 arg2Of RA,with

UBERON-AE

Id Subject Object Predicate Lexical cue
T12641 163-169 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue

GO-BP

Id Subject Object Predicate Lexical cue
T13131 303-315 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T13130 284-294 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T13129 278-294 http://purl.obolibrary.org/obo/GO_0038061 denotes NF-κB signalling
T13128 264-294 http://purl.obolibrary.org/obo/GO_1901222 denotes regulation of NF-κB signalling
T13123 264-274 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation

GO-CC

Id Subject Object Predicate Lexical cue
T13151 1039-1043 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T12654 1067-1231 Sentence denotes It will therefore be interesting to investigate whether SNPs that have been reported to be associated with systemic lupus erythematosus are also associated with RA.
T12653 783-1066 Sentence denotes A high degree of overlap between systemic lupus erythematosus and RA susceptibility loci might be expected as the two diseases show some clinical overlap in joint involvement, autoantibody production, systemic features and response to treatments such as B-cell depletion (rituximab).
T12652 659-782 Sentence denotes Interestingly, ABIN-1 polymorphisms have been associated with psoriasis and systemic lupus erythematosus in humans [61,62].
T12651 537-658 Sentence denotes Moreover, this protective effect of the ITAM was strongly suppressed in inflammatory arthritis synovial macrophages [60].
T12650 328-536 Sentence denotes In a recent study, inhibition of TLR responses by immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors was shown to depend on the expression of the NF-κB inhibitory proteins ABIN-3 and A20.
T12649 0-327 Sentence denotes Using oligonucleotide microarray analysis, ABIN-1 was identified among TNF-induced genes in human synoviocytes, and high levels of ABIN-1 mRNA were detected in RA tissue biopsies, indicating a potential role for ABIN-1, together with A20, in the negative feedback regulation of NF-κB signalling and the pathogenesis of RA [59].
T133 0-327 Sentence denotes Using oligonucleotide microarray analysis, ABIN-1 was identified among TNF-induced genes in human synoviocytes, and high levels of ABIN-1 mRNA were detected in RA tissue biopsies, indicating a potential role for ABIN-1, together with A20, in the negative feedback regulation of NF-κB signalling and the pathogenesis of RA [59].
T134 328-536 Sentence denotes In a recent study, inhibition of TLR responses by immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors was shown to depend on the expression of the NF-κB inhibitory proteins ABIN-3 and A20.
T135 537-658 Sentence denotes Moreover, this protective effect of the ITAM was strongly suppressed in inflammatory arthritis synovial macrophages [60].
T136 659-782 Sentence denotes Interestingly, ABIN-1 polymorphisms have been associated with psoriasis and systemic lupus erythematosus in humans [61,62].
T137 783-1066 Sentence denotes A high degree of overlap between systemic lupus erythematosus and RA susceptibility loci might be expected as the two diseases show some clinical overlap in joint involvement, autoantibody production, systemic features and response to treatments such as B-cell depletion (rituximab).
T138 1067-1231 Sentence denotes It will therefore be interesting to investigate whether SNPs that have been reported to be associated with systemic lupus erythematosus are also associated with RA.

ICD10

Id Subject Object Predicate Lexical cue
T13143 1183-1202 http://purl.bioontology.org/ontology/ICD10/L93 denotes lupus erythematosus
T13142 825-844 http://purl.bioontology.org/ontology/ICD10/L93 denotes lupus erythematosus
T13141 744-763 http://purl.bioontology.org/ontology/ICD10/L93 denotes lupus erythematosus
T13140 1174-1202 http://purl.bioontology.org/ontology/ICD10/M32 denotes systemic lupus erythematosus
T13139 816-844 http://purl.bioontology.org/ontology/ICD10/M32 denotes systemic lupus erythematosus
T13138 735-763 http://purl.bioontology.org/ontology/ICD10/M32 denotes systemic lupus erythematosus
T13137 1174-1202 http://purl.bioontology.org/ontology/ICD10/M32.9 denotes systemic lupus erythematosus
T13136 816-844 http://purl.bioontology.org/ontology/ICD10/M32.9 denotes systemic lupus erythematosus
T13135 735-763 http://purl.bioontology.org/ontology/ICD10/M32.9 denotes systemic lupus erythematosus
T13134 721-730 http://purl.bioontology.org/ontology/ICD10/L40.9 denotes psoriasis
T13133 721-730 http://purl.bioontology.org/ontology/ICD10/L40 denotes psoriasis
T13132 622-631 http://purl.bioontology.org/ontology/ICD10/M13.9 denotes arthritis

simple1

Id Subject Object Predicate Lexical cue
T13200 674-680 Protein denotes ABIN-1
T13199 532-535 Protein denotes A20
T13198 521-527 Protein denotes ABIN-3
T13197 234-237 Protein denotes A20
T13196 212-218 Protein denotes ABIN-1
T13195 131-137 Protein denotes ABIN-1
T13194 71-74 Protein denotes TNF
T13193 43-49 Protein denotes ABIN-1

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T13888 463-469 Regulation denotes depend
T13887 477-487 Gene_expression denotes expression
T13886 75-82 Positive_regulation denotes induced
T13885 121-127 Transcription denotes levels
T13873 674-680 Protein denotes ABIN-1
T13872 532-535 Protein denotes A20
T13871 521-527 Protein denotes ABIN-3
T13870 234-237 Protein denotes A20
T13869 212-218 Protein denotes ABIN-1
T13868 131-137 Protein denotes ABIN-1
T13867 71-74 Protein denotes TNF
T13866 43-49 Protein denotes ABIN-1
R9277 T13867 T13886 themeOf TNF,induced
R9278 T13868 T13885 themeOf ABIN-1,levels
R9280 T13872 T13887 themeOf A20,expression
R9281 T13887 T13888 themeOf expression,depend
R9282 T13887 T13888 themeOf expression,depend
R9279 T13871 T13887 themeOf ABIN-3,expression

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T13674 463-469 Regulation denotes depend
T13673 477-487 Gene_expression denotes expression
T13672 75-82 Positive_regulation denotes induced
T13658 674-680 Protein denotes ABIN-1
T13657 532-535 Protein denotes A20
T13656 521-527 Protein denotes ABIN-3
T13655 234-237 Protein denotes A20
T13654 212-218 Protein denotes ABIN-1
T13653 131-137 Protein denotes ABIN-1
T13652 71-74 Protein denotes TNF
T13651 43-49 Protein denotes ABIN-1
R9172 T13652 T13672 themeOf TNF,induced
R9173 T13656 T13673 themeOf ABIN-3,expression
R9174 T13657 T13673 themeOf A20,expression
R9175 T13673 T13674 themeOf expression,depend
R9176 T13673 T13674 themeOf expression,depend

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T13956 959-982 Gene_expression denotes autoantibody production
T13955 470-535 Gene_expression denotes on the expression of the NF-κB inhibitory proteins ABIN-3 and A20
T13954 71-111 Localization denotes TNF-induced genes in human synoviocytes,
T13953 71-111 Gene_expression denotes TNF-induced genes in human synoviocytes,
T13952 71-111 Positive_regulation denotes TNF-induced genes in human synoviocytes,
T13950 547-657 Negative_regulation denotes this protective effect of the ITAM was strongly suppressed in inflammatory arthritis synovial macrophages [60]
T13949 1223-1230 Protein denotes with RA
T13946 426-430 Entity denotes ITAM
T13943 43-49 Protein denotes ABIN-1
T13941 212-219 Protein denotes ABIN-1,
T13939 375-431 Entity denotes by immunoreceptor tyrosine-based activation motif (ITAM)
T13938 1055-1064 Entity denotes rituximab
T13937 275-294 Protein denotes of NF-κB signalling
T13936 488-535 Protein denotes of the NF-κB inhibitory proteins ABIN-3 and A20
T13932 71-111 Protein denotes TNF-induced genes in human synoviocytes,
T13931 160-162 Protein denotes RA
T13926 234-326 Protein denotes A20, in the negative feedback regulation of NF-κB signalling and the pathogenesis of RA [59]
T13918 532-535 Protein denotes A20
T13917 609-657 Entity denotes inflammatory arthritis synovial macrophages [60]
T13915 674-694 Protein denotes ABIN-1 polymorphisms
T13914 570-581 Entity denotes of the ITAM
T13911 92-111 Entity denotes human synoviocytes,
T13910 131-142 Protein denotes ABIN-1 mRNA
T13908 431-449 Protein denotes -coupled receptors
T13907 521-527 Protein denotes ABIN-3
T13904 959-971 Protein denotes autoantibody
T13901 131-137 Protein denotes ABIN-1
T13898 71-82 Protein denotes TNF-induced
T13897 319-321 Protein denotes RA
T13896 495-500 Protein denotes NF-κB
T13894 1037-1043 Entity denotes B-cell
T13891 849-851 Protein denotes RA
T13890 0-41 Entity denotes Using oligonucleotide microarray analysis
R9283 T13898 T13952 causeOf TNF-induced,"TNF-induced genes in human synoviocytes,"
R9285 T13904 T13956 themeOf autoantibody,autoantibody production
R9286 T13911 T13954 locationOf "human synoviocytes,","TNF-induced genes in human synoviocytes,"
R9289 T13932 T13952 themeOf "TNF-induced genes in human synoviocytes,","TNF-induced genes in human synoviocytes,"
R9290 T13932 T13953 themeOf "TNF-induced genes in human synoviocytes,","TNF-induced genes in human synoviocytes,"
R9291 T13932 T13954 themeOf "TNF-induced genes in human synoviocytes,","TNF-induced genes in human synoviocytes,"
R9292 T13936 T13955 themeOf of the NF-κB inhibitory proteins ABIN-3 and A20,on the expression of the NF-κB inhibitory proteins ABIN-3 and A20

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T13802 595-605 Negative_regulation denotes suppressed
T13801 577-581 Protein denotes ITAM
T13800 463-469 Regulation denotes depend
T13799 463-469 Regulation denotes depend
T13798 463-469 Regulation denotes depend
T13797 477-487 Gene_expression denotes expression
T13796 477-487 Gene_expression denotes expression
T13795 477-487 Gene_expression denotes expression
T13794 347-357 Negative_regulation denotes inhibition
T13793 532-535 Protein denotes A20
T13792 512-527 Protein denotes proteins ABIN-3
T13791 495-500 Protein denotes NF-κB
T13790 361-364 Protein denotes TLR
T13789 121-127 Positive_regulation denotes levels
T13788 278-283 Protein denotes NF-κB
T13787 131-142 Protein denotes ABIN-1 mRNA
T13786 71-74 Protein denotes TNF
R9229 T13787 T13789 themeOf ABIN-1 mRNA,levels
R9230 T13790 T13794 themeOf TLR,inhibition
R9231 T13791 T13795 themeOf NF-κB,expression
R9232 T13792 T13796 themeOf proteins ABIN-3,expression
R9233 T13793 T13797 themeOf A20,expression
R9234 T13795 T13798 themeOf expression,depend
R9235 T13796 T13799 themeOf expression,depend
R9236 T13797 T13800 themeOf expression,depend
R9237 T13798 T13794 Cause depend,inhibition
R9238 T13799 T13794 Cause depend,inhibition
R9239 T13800 T13794 Cause depend,inhibition
R9240 T13801 T13802 themeOf ITAM,suppressed

test3

Id Subject Object Predicate Lexical cue
T12639 674-680 Protein denotes ABIN-1
T12638 532-535 Protein denotes A20
T12637 521-527 Protein denotes ABIN-3
T12636 477-487 Gene_expression denotes expression
T12635 234-237 Protein denotes A20
T12634 212-218 Protein denotes ABIN-1
T12633 203-207 Regulation denotes role
T12632 131-137 Protein denotes ABIN-1
T12631 116-120 Positive_regulation denotes high
T12630 75-82 Positive_regulation denotes induced
T12629 71-74 Protein denotes TNF
T12628 43-49 Protein denotes ABIN-1
T12594 674-680 Protein denotes ABIN-1
T12593 532-535 Protein denotes A20
T12592 521-527 Protein denotes ABIN-3
T12591 234-237 Protein denotes A20
T12590 212-218 Protein denotes ABIN-1
T12589 131-137 Protein denotes ABIN-1
T12588 71-74 Protein denotes TNF
T12587 43-49 Protein denotes ABIN-1
R8334 T12630 T12633 themeOf induced,role
R8335 T12634 T12633 causeOf ABIN-1,role
R8336 T12637 T12636 themeOf ABIN-3,expression
R8337 T12638 T12636 themeOf A20,expression